View Document Preview and Link Open Document File Size: 1,44 MB Share Result on Facebook
Company GlaxoSmithKline / Novartis / Merck / / Facility University of Tennessee / American College of Endocrinology / University of Pennsylvania / Yale University / / IndustryTerm Diabetes Care / / MedicalCondition congestive heart failure AVANDIA / Cardiovascular Disease / diabetes / diabetes mellitus / microvascular disease / myocardial ischemia / / Organization Brown University / University of Pennsylvania / the American College / FDA / Massachusetts General Hospital / University of Tennessee / Yale University / American Society of Hypertension / American Association of Clinical Endocrinologists / / Person Hal Roseman / Hal M. Roseman / / Position Speaker / Specialist / / Product Pioglitazone / rosiglitazone maleate / Actos / Avandia / rosiglitazone / / ProvinceOrState Tennessee / Pennsylvania / Massachusetts / / PublishedMedium Endocrinology / / Technology AACE/ACE algorithm / 2009 AACE/ACE Glycemic Control Algorithm / html / / URL www.fda.gov/bbs/topics/NEWS/2007/NEW01636.html / http / SocialTag 
In Defense of Avandia (rosiglitazone) Hal Roseman, MD, MPH, FACC, FACP 1